Your browser doesn't support javascript.
loading
Assessment of Waldeyer's ring in pediatric and adolescent Hodgkin lymphoma patients-Importance of multimodality imaging: Results from the EuroNet-PHL-C1 trial.
Kurch, Lars; Mauz-Körholz, Christine; Fosså, Alexander; Georgi, Thomas Walther; Kluge, Regine; Bartelt, Jörg Martin; Kunze, Christian; Wohlgemuth, Walter Alexander; Pelz, Tanja; Vordermark, Dirk; Plößl, Sebastian; Hasenclever, Dirk; Sabri, Osama; Landman-Parker, Judith; Wallace, William Hamish; Karlen, Jonas; Fernández-Teijeiro, Ana; Cepelova, Michaela; Klekawka, Tomasz; Løndalen, Ayca Muftuler; Steiner, Dagmar; Krombach, Gabriele; Attarbaschi, Andishe; Hoffmann, Martha; Ceppi, Francesco; Pears, Jane; Hraskova, Andrea; Uyttebroeck, Anne; Beishuizen, Auke; Dieckmann, Karin; Leblanc, Thierry; Daw, Stephen; Körholz, Dieter; Stoevesandt, Dietrich.
Afiliación
  • Kurch L; Department of Nuclear Medicine, University of Leipzig, Leipzig, Germany.
  • Mauz-Körholz C; Department of Pediatric Hematology and Oncology, Justus-Liebig University, Gießen, Germany.
  • Fosså A; Medical Faculty of the Martin-Luther-University, Halle (Saale), Germany.
  • Georgi TW; Department of Medical Oncology and Radiotherapy, Oslo University Hospital, Oslo, Norway.
  • Kluge R; Department of Nuclear Medicine, University of Leipzig, Leipzig, Germany.
  • Bartelt JM; Department of Nuclear Medicine, University of Leipzig, Leipzig, Germany.
  • Kunze C; Department of Radiology, Medical Faculty of the Martin-Luther-University, Halle (Saale), Germany.
  • Wohlgemuth WA; Department of Radiology, Medical Faculty of the Martin-Luther-University, Halle (Saale), Germany.
  • Pelz T; Department of Radiology, Medical Faculty of the Martin-Luther-University, Halle (Saale), Germany.
  • Vordermark D; Department of Radiation Oncology, Medical Faculty of the Martin-Luther-University, Halle (Saale), Germany.
  • Plößl S; Department of Radiation Oncology, Medical Faculty of the Martin-Luther-University, Halle (Saale), Germany.
  • Hasenclever D; Department of Ear, Nose and Throat Medicine, Hospital Martha-Maria Halle, Halle (Saale), Germany.
  • Sabri O; Institute for Medical Informatics, Statistics and Epidemiology (IMISE), University of Leipzig, Leipzig, Germany.
  • Landman-Parker J; Department of Nuclear Medicine, University of Leipzig, Leipzig, Germany.
  • Wallace WH; Hôpital Armand-Trousseau Sorbonne Universitè, Paris, France.
  • Karlen J; Department of Paediatric Oncology, Royal Hospital for Sick Children, University of Edinburgh, Edinburgh, UK.
  • Fernández-Teijeiro A; Karolinska University Hospital, Astrid Lindgrens Childrens Hospital, Stockholm, Sweden.
  • Cepelova M; Pediatric Onco-Hematology Unit, Hospital Universitario Virgen Macarena, Sevilla, Spain.
  • Klekawka T; Department of Pediatric Hematology and Oncology, University Hospital Motol and, Second Medical Faculty of Charles University, Prague, Czech Republic.
  • Løndalen AM; Institute of Pediatrics, Jagiellonian University Medical College, Krakow, Poland.
  • Steiner D; Department of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.
  • Krombach G; Department of Nuclear Medicine, Justus-Liebig University Giessen, Giessen, Germany.
  • Attarbaschi A; Department of Radiology, Justus-Liebig University Giessen, Giessen, Germany.
  • Hoffmann M; Department of Pediatric Hematology and Oncology, St. Anna Children's Hospital, Medical University of Vienna, Vienna, Austria.
  • Ceppi F; Wiener Privatklinik, Radiology Centre, Vienna, Austria.
  • Pears J; Division of Pediatrics, Department of Woman-, Mother-Child, Pediatric Hematology-Oncology Unit, University Hospital of Lausanne, Lausanne, Switzerland.
  • Hraskova A; Department of Pediatric Hematology and Oncology, Our Lady's Children's Hospital, Dublin, Ireland.
  • Uyttebroeck A; Department of Pediatric Hematology and Oncology, University Children's Hospital, Bratislava, Slovakia.
  • Beishuizen A; Department of Pediatric Hematology and Oncology, University Hospitals Leuven, Leuven, Belgium.
  • Dieckmann K; Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands.
  • Leblanc T; Princess Màxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Daw S; Department of Radiation Oncology, University Hospital Vienna, Vienna, Austria.
  • Körholz D; Service d'Hématologie Pédiatrique, Hôpital Robert-Debré, Paris, France.
  • Stoevesandt D; Department of Pediatric Hematology and Oncology, University College London Hospitals, London, UK.
Pediatr Blood Cancer ; 68(4): e28903, 2021 04.
Article en En | MEDLINE | ID: mdl-33538093
ABSTRACT

BACKGROUND:

In the EuroNet Pediatric Hodgkin Lymphoma (EuroNet-PHL) trials, decision on Waldeyer's ring (WR) involvement is usually based on clinical assessment, that is, physical examination and/or nasopharyngoscopy. However, clinical assessment only evaluates mucosal surface and is prone to interobserver variability. Modern cross-sectional imaging technology may provide valuable information beyond mucosal surface, which may lead to a more accurate WR staging. PATIENTS, MATERIALS, AND

METHODS:

The EuroNet-PHL-C1 trial recruited 2102 patients, of which 1752 underwent central review including reference reading of their cross-sectional imaging data. In 14 of 1752 patients, WR was considered involved according to clinical assessment. In these 14 patients, the WR was re-assessed by applying an imaging-based algorithm considering information from 18 F-fluorodeoxyglucose positron emission tomography, contrast-enhanced computed tomography, and/or magnetic resonance imaging. For verification purposes, the imaging-based algorithm was applied to 100 consecutive patients whose WR was inconspicuous on clinical assessment.

RESULTS:

The imaging-based algorithm confirmed WR involvement only in four of the 14 patients. Of the remaining 10 patients, four had retropharyngeal lymph node involvement and six an inconspicuous WR. Applying the imaging-based algorithm to 100 consecutive patients with physiological appearance of their WR on clinical assessment, absence of WR involvement could be confirmed in 99. However, suspicion of WR involvement was raised in one patient.

CONCLUSIONS:

The imaging-based algorithm was feasible and easily applicable at initial staging of young patients with Hodgkin lymphoma. It increased the accuracy of WR staging, which may contribute to a more individualized treatment in the future.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin Tipo de estudio: Prognostic_studies Límite: Adolescent / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: Pediatr Blood Cancer Asunto de la revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Año: 2021 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin Tipo de estudio: Prognostic_studies Límite: Adolescent / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: Pediatr Blood Cancer Asunto de la revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Año: 2021 Tipo del documento: Article País de afiliación: Alemania